OBJECTIVE To describe the implications of a follow-on biologic approval process with focus on current stakeholders, implications of the status quo, and recommendations for future policy. DATA SOURCES A search using Medline, International Pharmaceutical Abstracts, Med Ad News, F-D-C Reports/Pink Sheets, and Google index directories was conducted with terms such as biologic, biopharmaceutical, ...

iran's economy dependence on oil revenues has caused some impacts in the form of commodity price fluctuations on current revenues. accordingly, in the past few years especially in the second development plan, the government included encouragements and reduced the country's dependence on oil revenues in its agenda. agricultural export, especially livestock and poultry export has a proper status ...

Phytochemicals have potent antitumor properties and have provided multiple active compounds in the past. Although there is an increasing focus on 'designer' targeted therapeutic anticancer agents, the broad spectrum of activity of natural products across multiple signaling pathways remains inadequately explored. The chemical diversity, structural complexity, affordability, lack of substantial t...

Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of "comparability" or "no clinically meaningful differences" as compared to its reference biologic ...

Organic agriculture is rapidly growing while the lack of knowledge and skills to manage organic farms and the lack of market opportunities for the organic products are the most important reasons for the disinclination to the use of the organic agriculture practices. The main aim of this study was to determine the factors underpinning the marketing of organic agriculture products. The research w...